Consolidated Statement of Cash Flows (Predecessor Basis)	3 Months Ended
	Sep. 30, 2020 USD ($)
Cash flows from operating activities:
Net decrease in net assets resulting from operations	$ (2,447,213)
Adjustments to reconcile net decrease in net assets resulting from operations to net cash from operating activities:
Proceeds from sale of investments, net	5,204,809
Return of capital	4,284,031
Purchase of investments	(7,412,967)
Net realized gains on investments	(1,016,352)
Net unrealized loss on investments	3,176,065
Amortization of deferred offering costs	141,889
Changes in assets and liabilities:
Accounts receivable	175,892
Due from related entities	(154,865)
Other assets	30,065
Payment of deferred offering costs	(25,389)
Accounts payable and accrued liabilities	(85,179)
Due to related entities	(41,230)
Net cash from operating activities	1,829,556
Cash flows from financing activities:
Proceeds from issuance of common stock	160,739
Payment of selling commissions and fees	(6,399)
Change in capital pending acceptance	(78,739)
Net cash from financing activities	75,601
Net increase in cash and restricted cash equivalents	1,905,157
Cash, cash equivalents and restricted cash at beginning of the period	8,957,393
Cash, cash equivalents and restricted cash at end of the period	$ 10,862,550